"prostate tumor progression" trang 14 - tải miễn phí từ tailieunhanh
An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol

An exploration of men’s experiences of undergoing active surveillance for favourable-risk prostate cancer: A mixed methods study protocol
8    46    1
A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease

A retrospective analysis of Victorian and South Australian clinical registries for prostate cancer: Trends in clinical presentation and management of the disease
11    79    1
Heterogeneity of ERG expression in prostate cancer: A large section mapping study of entire prostatectomy specimens from 125 patients

Heterogeneity of ERG expression in prostate cancer: A large section mapping study of entire prostatectomy specimens from 125 patients
10    69    1
Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: A cluster randomised controlled trial

Nurse-led group consultation intervention reduces depressive symptoms in men with localised prostate cancer: A cluster randomised controlled trial
12    42    1
Stroke related to androgen deprivation therapy for prostate cancer: A meta-analysis and systematic review

Stroke related to androgen deprivation therapy for prostate cancer: A meta-analysis and systematic review
7    50    1
Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer

Nemo-like kinase as a negative regulator of nuclear receptor Nurr1 gene transcription in prostate cancer
12    48    1
After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer

After low and high dose-rate interstitial brachytherapy followed by IMRT radiotherapy for intermediate and high risk prostate cancer
10    57    1
Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial

Focal vs extended ablation in localized prostate cancer with irreversible electroporation; a multi-center randomized controlled trial
9    38    1
18F-fluoride positron emission tomography/ computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: Study protocol for a multicentre, diagnostic test accuracy study

18F-fluoride positron emission tomography/ computed tomography and bone scintigraphy for diagnosis of bone metastases in newly diagnosed, high-risk prostate cancer patients: Study protocol for a multicentre, diagnostic test accuracy study
8    71    1
Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy

Platelet to lymphocyte ratio as an independent prognostic indicator for prostate cancer patients receiving androgen deprivation therapy
8    60    1
Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen

Corepressive function of nuclear receptor coactivator 2 in androgen receptor of prostate cancer cells treated with antiandrogen
8    27    1
Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: Results from a multicentre prospective study

Metabolic syndrome is associated with advanced prostate cancer in patients treated with radical retropubic prostatectomy: Results from a multicentre prospective study
8    39    1
Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: A descriptive study

Incidence of prostate and urological cancers in England by ethnic group, 2001-2007: A descriptive study
12    79    1
Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells

Molecular evidence of IGFBP-3 dependent and independent VD3 action and its nonlinear response on IGFBP-3 induction in prostate cancer cells
13    22    1
A machine learning approach to optimizing cell-free DNA sequencing panels: With an application to prostate cancer

A machine learning approach to optimizing cell-free DNA sequencing panels: With an application to prostate cancer
9    45    1
Current opinion on the role of testosterone in the development of prostate cancer: A dynamic model

Current opinion on the role of testosterone in the development of prostate cancer: A dynamic model
8    66    1
Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: Caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy

Prognostic value of inhibitors of apoptosis proteins (IAPs) and caspases in prostate cancer: Caspase-3 forms and XIAP predict biochemical progression after radical prostatectomy
9    60    1
Risk of fracture in men with prostate cancer on androgen deprivation therapy: A population-based cohort study in New Zealand

Risk of fracture in men with prostate cancer on androgen deprivation therapy: A population-based cohort study in New Zealand
10    30    1
Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells

Curcumin analog WZ35 induced cell death via ROS-dependent ER stress and G2/M cell cycle arrest in human prostate cancer cells
11    46    1
Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: A randomized controlled phase II a trial
8    55    1